Search Results

ATP, a leader in life sciences venture capital, today announced the launch of Adendra Therapeutics Ltd, a spin-out of immunology research conducted at the Francis Crick Institute in the lab of Caetano Reis e Sousa.

In December 2021, ATP, a leader in life sciences venture capital, announced the launch of Adendra Therapeutics Ltd, a spin-out of immunology research by Crick Principal Group Leader Caetano Reis e Sousa and his team. One year on, Caetano explains why working with ATP on early stage discovery research in his lab has been key to the early success of Adendra.

Researchers at the Francis Crick Institute and GSK will extend their ongoing collaboration to advance the discovery of new drug targets in a £11.5million effort, thanks to a ‘Prosperity Partnership’ grant from the Engineering and Physical Sciences Research Council (EPSRC) and matching funds from GSK.

Ten innovative startups, operating at the intersection of data and biomedical science, have been selected to take part in the KQ Labs accelerator programme.

KQ Labs opens applications for early stage data-driven health start-ups for its fourth annual accelerator programme.

KQ Labs, an accelerator programme focused on data-driven health, run by the Crick and now funded by LifeArc, has selected ten new start-ups for its third cohort.  

Innovate UK is investing £400,000 to launch KQ Labs, an accelerator programme at the Francis Crick Institute to support start-ups working at the interface between biomedical and data science.

Researchers at the Francis Crick Institute, Imperial College London and AstraZeneca will advance the discovery of new ‘molecular glues’ to treat a range of different diseases, thanks to a £11.2million combined investment, including a Prosperity Partnership grant from the Engineering and Physical Sciences Research Council (EPSRC) and matching funds from AstraZeneca.

Ervaxx, a cancer therapy company based on the work of the Crick’s George Kassiotis, has launched today.

Artios Pharma Limited (Artios), a biotech company established with the help and expertise of Francis Crick Institute senior group leader Simon Boulton, is to partner with Merck.